Mankind Pharma Peer Comparison

NSE: MANKIND | BSE: 543904

₹2,626.60

up-down-arrow ₹-13.40 (-0.51%)

As on 16-Nov-2026IST

Market cap

info icon

₹1,08,424 Cr

Revenue (TTM)

info icon

₹15,379 Cr

P/E Ratio

info icon

48.3

P/B Ratio

info icon

6.2

Div. Yield

info icon

0 %

Edit peer-selector-edit
Mankind Pharma Zydus Lifesciences Dr. Reddy'S Labs Aurobindo Pharma Lupin
Market cap (₹ Cr)
1,08,424 1,18,603 1,15,267 1,02,878 90,201
Revenue (₹ Cr)
15,379 30,378 33,097 36,913 30,746
Net Profit (₹ Cr)
2,249.69 4,159.00 2,759.70 3,993.05 5,221.47
Net Margin (%)
14.32 13.20 8.03 10.61 16.70
RoE (%)
13.86 16.61 7.30 10.51 24.24
Price to Earnings
48.35 28.37 41.17 25.78 17.33
Price-To-Book
6.17 4.26 2.97 2.61 3.75

Income Statement (₹ Cr)

Liabilities (₹ Cr)

Assets (₹ Cr)

Cashflow (₹ Cr)

Ratios

Profitability Ratios

Growth Ratios

Valuation Ratios

Solvency Ratios

Operating Efficiency Ratios

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month